Idenix Home
home | contact us | careers | search | glossary of terms | site map

News Releases

Receive E-mail AlertsE-mail Alerts
|
RSS Feeds RSS
Webcast ImageWebcast
Q2 2010 Idenix Pharmaceuticals, Inc. Earnings Conference Call (Replay)
07/26/10 at 4:30 p.m. ET
Webcast ImageWebcast
Idenix Pharmaceuticals, Inc. at Wedbush Morgan Securities Life Sciences Best Ideas MAC: Management Access Conference (Live)
08/03/10 at 4:10 p.m. ET
Webcast ImageWebcast
Idenix Pharmaceuticals, Inc. at BMO Capital Markets Focus on Healthcare Conference (Live)
08/05/10 at 4:00 p.m. ET
Keyword Search
 
2010 | 2009 | 2008 | 2007 | 2006
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
07/27/10
Idenix Pharmaceuticals Reports Second Quarter 2010 Financial Results and Provides Research and Development Update on HCV Programs
07/26/10
Idenix to Host Conference Call Discussing Second Quarter 2010 Financial Results
07/19/10
Idenix Pharmaceuticals to Present at the 2010 Wells Fargo Securities Healthcare Conference
06/16/10
Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients
06/10/10
Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
05/19/10
Idenix Pharmaceuticals to Present at The Rodman & Renshaw 6th Annual Global Healthcare Conference
05/10/10
Idenix Pharmaceuticals Reports Progress on Clinical Programs and First Quarter 2010 Financial Results
05/03/10
Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
04/29/10
Idenix to Host Conference Call Discussing First Quarter 2010 Financial Results
04/22/10
Idenix Pharmaceuticals Reports Favorable Pharmacokinetic Data for IDX320, a Potent, Multi-Genotypic Protease Inhibitor for the Treatment of Hepatitis C
04/16/10
Idenix Pharmaceuticals Reports Positive Results With IDX184 From Interim Analysis of Phase IIa Hepatitis C Study
04/15/10
Idenix Pharmaceuticals Appoints Tamar D. Howson to Its Board of Directors
03/30/10
Idenix Pharmaceuticals to Present at the Canaccord Adams' Hepatitis C Conference
03/26/10
Idenix Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
03/17/10
Idenix Announces Data Presentations at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL)
03/16/10
Idenix Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
03/02/10
Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
02/25/10
Idenix to Host Conference Call Discussing Fourth Quarter and Year End 2009 Financial Results
02/11/10
Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conference
02/01/10
Idenix Pharmaceuticals Highlights Progress in Three HCV Programs
01/11/10
Idenix Pharmaceuticals to Present at the 28th Annual J. P. Morgan Healthcare Conference
01/04/10